296 related articles for article (PubMed ID: 26857068)
1. γ-Glutamyltransferase and Risk of Sudden Cardiac Death in Middle-Aged Finnish Men: A New Prospective Cohort Study.
Kunutsor SK; Khan H; Laukkanen JA
J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26857068
[TBL] [Abstract][Full Text] [Related]
2. Lipoprotein(a) and risk of sudden cardiac death in middle-aged Finnish men: A new prospective cohort study.
Kunutsor SK; Khan H; Nyyssönen K; Laukkanen JA
Int J Cardiol; 2016 Oct; 220():718-25. PubMed ID: 27393854
[TBL] [Abstract][Full Text] [Related]
3. Gamma-glutamyltransferase and risk of prostate cancer: Findings from the KIHD prospective cohort study.
Kunutsor SK; Laukkanen JA
Int J Cancer; 2017 Feb; 140(4):818-824. PubMed ID: 27861848
[TBL] [Abstract][Full Text] [Related]
4. Baseline and long-term fibrinogen levels and risk of sudden cardiac death: A new prospective study and meta-analysis.
Kunutsor SK; Kurl S; Zaccardi F; Laukkanen JA
Atherosclerosis; 2016 Feb; 245():171-80. PubMed ID: 26724527
[TBL] [Abstract][Full Text] [Related]
5. Baseline and long-term gamma-glutamyltransferase, heart failure and cardiac arrhythmias in middle-aged Finnish men: Prospective study and pooled analysis of published evidence.
Kunutsor SK; Laukkanen JA; Bluemke DA; Butler J; Khan H
Eur J Prev Cardiol; 2016 Sep; 23(13):1354-62. PubMed ID: 27084895
[TBL] [Abstract][Full Text] [Related]
6. Gamma glutamyltransferase and risk of future dementia in middle-aged to older Finnish men: A new prospective cohort study.
Kunutsor SK; Laukkanen JA
Alzheimers Dement; 2016 Sep; 12(9):931-941. PubMed ID: 27103259
[TBL] [Abstract][Full Text] [Related]
7. Circulating gamma glutamyltransferase and prediction of cardiovascular disease.
Kunutsor SK; Bakker SJ; Kootstra-Ros JE; Gansevoort RT; Dullaart RP
Atherosclerosis; 2015 Feb; 238(2):356-64. PubMed ID: 25555268
[TBL] [Abstract][Full Text] [Related]
8. Gamma-Glutamyltransferase and Future Risk of Pneumonia: A Long-Term Prospective Cohort Study.
Kunutsor SK; Laukkanen JA
Lung; 2017 Dec; 195(6):799-803. PubMed ID: 28993933
[TBL] [Abstract][Full Text] [Related]
9. Gamma-glutamyltransferase and risk of chronic kidney disease: A prospective cohort study.
Kunutsor SK; Laukkanen JA
Clin Chim Acta; 2017 Oct; 473():39-44. PubMed ID: 28811239
[TBL] [Abstract][Full Text] [Related]
10. Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study.
Lee DS; Evans JC; Robins SJ; Wilson PW; Albano I; Fox CS; Wang TJ; Benjamin EJ; D'Agostino RB; Vasan RS
Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):127-33. PubMed ID: 17095717
[TBL] [Abstract][Full Text] [Related]
11. Serum γ-glutamyltransferase: independent predictor of risk of diabetes, hypertension, metabolic syndrome, and coronary disease.
Onat A; Can G; Örnek E; Çiçek G; Ayhan E; Doğan Y
Obesity (Silver Spring); 2012 Apr; 20(4):842-8. PubMed ID: 21633402
[TBL] [Abstract][Full Text] [Related]
12. Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults.
Ruttmann E; Brant LJ; Concin H; Diem G; Rapp K; Ulmer H;
Circulation; 2005 Oct; 112(14):2130-7. PubMed ID: 16186419
[TBL] [Abstract][Full Text] [Related]
13. Beat-to-beat spatiotemporal variability in the T vector is associated with sudden cardiac death in participants without left ventricular hypertrophy: the Atherosclerosis Risk in Communities (ARIC) Study.
Waks JW; Soliman EZ; Henrikson CA; Sotoodehnia N; Han L; Agarwal SK; Arking DE; Siscovick DS; Solomon SD; Post WS; Josephson ME; Coresh J; Tereshchenko LG
J Am Heart Assoc; 2015 Jan; 4(1):e001357. PubMed ID: 25600143
[TBL] [Abstract][Full Text] [Related]
14. Ultrasonographic hepatic steatosis increases prediction of mortality risk from elevated serum gamma-glutamyl transpeptidase levels.
Haring R; Wallaschofski H; Nauck M; Dörr M; Baumeister SE; Völzke H
Hepatology; 2009 Nov; 50(5):1403-11. PubMed ID: 19670414
[TBL] [Abstract][Full Text] [Related]
15. Joint effects of coffee consumption and serum gamma-glutamyltransferase on the risk of liver cancer.
Hu G; Tuomilehto J; Pukkala E; Hakulinen T; Antikainen R; Vartiainen E; Jousilahti P
Hepatology; 2008 Jul; 48(1):129-36. PubMed ID: 18537182
[TBL] [Abstract][Full Text] [Related]
16. Metabolic syndrome and the risk of sudden cardiac death in middle-aged men.
Kurl S; Laaksonen DE; Jae SY; Mäkikallio TH; Zaccardi F; Kauhanen J; Ronkainen K; Laukkanen JA
Int J Cardiol; 2016 Jan; 203():792-7. PubMed ID: 26595786
[TBL] [Abstract][Full Text] [Related]
17. Γ-glutamyltransferase, hepatic enzymes, and risk of incident heart failure in older men.
Wannamethee SG; Whincup PH; Shaper AG; Lennon L; Sattar N
Arterioscler Thromb Vasc Biol; 2012 Mar; 32(3):830-5. PubMed ID: 22223732
[TBL] [Abstract][Full Text] [Related]
18. Serum gamma-glutamyltransferase is a predictor of incident coronary events in apparently healthy men from the general population.
Meisinger C; Döring A; Schneider A; Löwel H;
Atherosclerosis; 2006 Dec; 189(2):297-302. PubMed ID: 16483579
[TBL] [Abstract][Full Text] [Related]
19. Predictive value of electrocardiographic T-wave morphology parameters and T-wave peak to T-wave end interval for sudden cardiac death in the general population.
Porthan K; Viitasalo M; Toivonen L; Havulinna AS; Jula A; Tikkanen JT; Väänänen H; Nieminen MS; Huikuri HV; Newton-Cheh C; Salomaa V; Oikarinen L
Circ Arrhythm Electrophysiol; 2013 Aug; 6(4):690-6. PubMed ID: 23881778
[TBL] [Abstract][Full Text] [Related]
20. Coffee consumption, serum gamma-glutamyltransferase and risk of type II diabetes.
Bidel S; Silventoinen K; Hu G; Lee DH; Kaprio J; Tuomilehto J
Eur J Clin Nutr; 2008 Feb; 62(2):178-85. PubMed ID: 17342160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
